Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Drug Delivery|May 31, 2022
A non-invasive direct nose to brain drug delivery platform vs. invasive brain delivery approach: patient-centered care impact analysisAyala Kobo-Greenhut, Hilel Frankenthal, Aziz Darawsha, et al.
Diabetes Care|August 6, 2014
Cognitive function and the risk for diabetes among young menGilad Twig, Israel Gluzman, Amir Tirosh, et al.
Journal of the American College of Cardiology|March 16, 2018
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 StudyMikhail Kosiborod, Carolyn S P Lam, Shun Kohsaka, et al.
Heart (British Cardiac Society)|February 13, 2023
Prevalence, outcomes and costs of a contemporary, multinational population with heart failureAnna Norhammar, Johan Bodegard, Marc Vanderheyden, et al.
Diabetes Research and Clinical Practice|May 24, 2019
CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzleGuntram Schernthaner, Christoph Wanner, Dubravka Jurišić-Eržen, et al.
The Lancet Regional Health. Europe|September 12, 2022
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD studyJohan Sundström, Johan Bodegard, Andreas Bollmann, et al.
Cardiovascular Diabetology|September 2, 2019
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTsGuntram Schernthaner, Avraham Karasik, Agnė Abraitienė, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2005
Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cellsTamar Sapir, Keren Shternhall, Irit Meivar-Levy, et al.
Diabetes Care|October 25, 2022
Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and IsraelBeini Lyu, Yingying Sang, Elizabeth Selvin, et al.
Diabetes, Obesity & Metabolism|March 24, 2022
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countriesAnna Norhammar, Johan Bodegard, Jan W Eriksson, et al.
Pageof 7